NCT01022970 - Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 29, 2012

Conditions

Eosinophilic Esophagitis

Interventions

DRUG

QAX576 placebo

DRUG

QAX576

Trial Locations (5)

Oral Alpan, 6210 Old Keene Mill Court,, Springfield

Cincinnati Children's Hospital Medical Center, Cincinnati

Mayo Clinic, Minneota

Northwestern University Feinberg School of Medicine, Chicago

Stanford Medical Center and Lucile Packard Children's Hospital, Stanford